Bicara Therapeutics Inc. (BCAX) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bicara Therapeutics Inc..

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a0425b-526b-7370-81e3-aa6e2dc770f5 Created: 2026-08-27T08:34:38.098Z Duration: 2697.9788 Channels: 1 00:00:00.000 -- 00:00:02.479 Good day and thank you for standing by. 00:00:02.720 -- 00:00:04.880 Welcome to the Bicara Therapeutics 00:00:04.880 -- 00:00:08.080 First Quarter twenty twenty six Earnings Conference Call. 00:00:08.400 -- 00:00:10.880 At this time, all participants are in a 00:00:10.880 -- 00:00:11.840 listen only mode. 00:00:12.495 -- 00:00:14.975 After the speakers' presentation, there will be a 00:00:14.975 -- 00:00:16.575 question and answer session. 00:00:17.055 -- 00:00:19.055 To ask a question during the session, you 00:00:19.055 -- 00:00:20.575 will need to press 11 00:00:20.575 -- 00:00:21.695 on your telephone. 00:00:21.935 -- 00:00:24.175 You will then hear an automated message advising 00:00:24.175 -- 00:00:25.215 your hand is raised. 00:00:25.789 -- 00:00:26.509 Please 00:00:30.189 -- 00:00:33.149 be advised that today's conference is being recorded. 00:00:33.470 -- 00:00:35.309 I would now like to hand the conference 00:00:35.309 -- 00:00:37.629 over to your first speaker today, Rachel Frank, 00:00:37.885 -- 00:00:41.885 Vice President of Investor Relations and Corporate Communications. 00:00:42.125 -- 00:00:43.324 Please go ahead. 00:00:47.004 -- 00:00:49.004 Thank you, and good morning, everyone. It's a 00:00:49.004 -- 00:00:51.405 pleasure to welcome you to Bicara Therapeutics First 00:00:51.405 -- 00:00:54.579 Quarter twenty twenty six Earnings Call. Earlier this 00:00:54.579 -- 00:00:56.899 morning, we issued a press release highlighting results 00:00:56.899 -- 00:00:59.140 from the quarter and recent business progress. 00:00:59.300 -- 00:01:01.059 You can access the press re...